1. Home
  2. ATLX vs IMUX Comparison

ATLX vs IMUX Comparison

Compare ATLX & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlas Lithium Corporation

ATLX

Atlas Lithium Corporation

HOLD

Current Price

$5.04

Market Cap

92.2M

Sector

Industrials

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.71

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLX
IMUX
Founded
2011
2016
Country
Brazil
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.2M
85.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATLX
IMUX
Price
$5.04
$0.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$6.00
AVG Volume (30 Days)
546.2K
1.2M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,454.00
N/A
Revenue This Year
$22,084.55
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$0.56
52 Week High
$8.32
$1.42

Technical Indicators

Market Signals
Indicator
ATLX
IMUX
Relative Strength Index (RSI) 49.57 44.84
Support Level $4.50 $0.67
Resistance Level $5.15 $0.73
Average True Range (ATR) 0.48 0.05
MACD 0.07 0.00
Stochastic Oscillator 49.35 35.64

Price Performance

Historical Comparison
ATLX
IMUX

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: